All Sauce from Weekly Sauce:

A California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stress disorder (PTSD). When announcing the new drug application (NDA) filing on Tuesday, MAPS Public Benefit Corp. noted it has been studying the drug for this…  read on >  read on >

A healthy plant-based diet can reduce a person’s risk of type 2 diabetes by 24%, a new study has found. Eating plenty of fresh fruits, vegetables and whole grains has this protective effect even in people with a genetic predisposition for diabetes or risk factors like obesity, advanced age or lack of physical activity, researchers…  read on >  read on >

Doctor’s brains are great decision-makers, but even the smartest physicians might be well-served with a little diagnostic help from ChatGPT, a new study suggests. The main benefit comes from a thinking process known as “probabilistic reasoning” — knowing the odds that something will (or won’t) happen. “Humans struggle with probabilistic reasoning, the practice of making…  read on >  read on >

Marijuana use by expecting moms is associated with unhealthy pregnancy outcomes, especially low birth weight babies, a new study finds. Further, heavier weed use is associated with higher risks for the pregnancy, the researchers added. “Cannabis use is not safe,” said senior researcher Dr. Robert Silver, a professor of obstetrics and gynecology at University of…  read on >  read on >

Many Americans battling diabetes are turning to a new class of injected drugs that includes blockbusters like Ozempic (semaglutide) and Mounjaro (tirzepatide). But a new study finds half of patients who use these “second line” therapies — a class called GLP-1 RAs — quit them within a year. The main factor: Gastrointestinal issues like nausea, vomiting…  read on >  read on >